Search for: "Levell v. State" Results 2661 - 2680 of 29,813
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Nov 2022, 9:05 pm by Zoe Stern
A state judge overturned Georgia’s ban on abortion after six weeks of pregnancy, ruling that it violated Roe v. [read post]
17 Nov 2022, 5:26 pm by Patricia Salkin
The later section is less strict and states that a yard which is higher than curb level should not have its “natural grade level disturbed” solely to ensure compliance with the section. [read post]
17 Nov 2022, 4:00 am by Guest Author
EPA and more in the concerns animating Justice Jackson’s concurrence in Youngstown Sheet & Tube Co. v. [read post]
17 Nov 2022, 12:00 am by Thalia Kruger
In practice, ex lege powers of representation may be the subject of cooperation between the authorities of Contracting Parties (notably as provided for under Chapter V), but, where the issue arises of the existence, the extent and the exercise of such powers, the courts and other authorities of Contracting States will rely on their own law, including, where appropriate, their conflict-of-laws rules. [read post]
15 Nov 2022, 7:15 pm by JP Zanders
In their review of the articles, state parties will have to acknowledge the invocation of Articles V and VI. [read post]
15 Nov 2022, 10:00 am by Guest Author
”  This observation, one of my favorites in the widely taught United States v. [read post]
15 Nov 2022, 10:00 am by Liz Hempowicz
At the federal level, Congress codified quo warranto in the District of Columbia Code. [read post]
15 Nov 2022, 5:56 am by Jonathan Hafetz
Then, when the Supreme Court effectively confirmed that CIA black sites were unlawful in 2006 by ruling in Hamdan v. [read post]
14 Nov 2022, 5:01 am by Anastasia Bradatan
Mehta found that the court must give the highest level of deference to the executive’s position that active hostilities continue to exist. [read post]
14 Nov 2022, 2:55 am by Gabriele Girardello
  The discussion highlighted the difficult relationship between regulatory departments and IP departments in pharmaceutical companies, in relation to what must/should not be published prior to patent filing and in relation to the level of detail of clinical studies, whether at a more or less advanced stage, required to support valid patent applications. [read post]